White, William B <br/><br/>
Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities.  [electronic resource] 

 -  American heart journal  Jul 2012 
 - 14-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2012.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allopurinol--adverse effects<br/>Cardiovascular Diseases--complications<br/>Double-Blind Method<br/>Febuxostat<br/>Gout--complications<br/>Gout Suppressants--adverse effects<br/>Humans<br/>Prospective Studies<br/>Thiazoles--adverse effects